Trial Profile
A phase I trial of amplimexon (Imexon, Inj.) plus gemcitabine in previously treated inoperable stage III and stage IV non-small cell lung cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2006
Price :
$35
*
At a glance
- Drugs Imexon (Primary) ; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 20 Jan 2006 New trial record.